10P Safety and tolerability of first-line (1L) osimertinib (osi) ± platinum-pemetrexed in EGFRm advanced NSCLC: Data from FLAURA2
Lee, C.K., Planchard, D., Fan, Y., Poltoratskiy, A., Tran, T.V., Leiva Gálvez, M.H., Nishino, K., Yao, W., Biswas, B., Takahashi, T., Nerón, Y., Sriuranpong, V., Koubkova, L., Han, J-Y., Figueroa, A., Ruscanu, C., Taggart, S., Kulkarni, D., Albayaty, M., Escriu, C.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article